-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Targeting Latently Infected Cells Without Reactivation (RO1).
Date: December 8-9, 2014.
Time: December 8, 2014, 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 4H100, MSC 9823, 5601 Fishers Lane, Bethesda, MD 20817 (Telephone Conference Call).
Time: December 9, 2014, 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3F100, MSC 9823, 5601 Fishers Lane, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Robert C. Unfer, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, Room 3F40B, MSC 9823, Rockville, Maryland 20892, 240-669-5035, unferrc@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Start SignatureDated: November 12, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-27340 Filed 11-18-14; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Effective Date:
- 12/8/2014
- Published:
- 11/19/2014
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2014-27340
- Dates:
- December 8-9, 2014.
- Pages:
- 68893-68893 (1 pages)
- PDF File:
- 2014-27340.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute